Willich N - Search Results

1

Functional evaluation of the human pancreas before and in the early period after hyperfractionated accelerated radiochemotherapy.

Horst E, Seidel M, Micke O, Rübe C, Schäfer U, Willich N. Horst E, et al. Among authors: willich n. Front Radiat Ther Oncol. 2002;37:17-25. doi: 10.1159/000061312. Front Radiat Ther Oncol. 2002. PMID: 11764659 No abstract available.

2

Accelerated radiochemotherapy in pancreatic cancer is not necessarily related to a pathologic pancreatic function decline in the early period.

Horst E, Seidel M, Micke O, Rübe C, Glashörster M, Schäfer U, Willich NA. Horst E, et al. Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):304-9. doi: 10.1016/s0360-3016(01)02594-9. Int J Radiat Oncol Biol Phys. 2002. PMID: 11872274

3

Predictive value of carbohydrate antigen 19-9 in pancreatic cancer treated with radiochemotherapy.

Micke O, Bruns F, Kurowski R, Horst E, deVries AF, Hausler JW, Willich N, Schäfer U. Micke O, et al. Among authors: willich n. Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):90-7. doi: 10.1016/s0360-3016(03)00524-8. Int J Radiat Oncol Biol Phys. 2003. PMID: 12909220 Clinical Trial.

4

Results and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy.

Micke O, Hesselmann S, Bruns F, Horst E, Devries A, Schüller P, Willich N, Schäfer U. Micke O, et al. Among authors: willich n. Anticancer Res. 2005 May-Jun;25(3A):1523-30. Anticancer Res. 2005. PMID: 16033054 Free article.

5

Conformal therapy for pancreatic cancer: variation of organ position due to gastrointestinal distention--implications for treatment planning.

Horst E, Micke O, Moustakis C, Schuck A, Schäfer U, Willich NA. Horst E, et al. Radiology. 2002 Mar;222(3):681-6. doi: 10.1148/radiol.2223010639. Radiology. 2002. PMID: 11867785

6

Combined radiochemotherapy with paclitaxel in the treatment of malignant glioma.

Schuck A, Müller SB, Köhler A, Könemann S, Wienstroer M, Mosler C, Rübe CE, Wassmann H, Willich N, Rübe C. Schuck A, et al. Among authors: willich n. Strahlenther Onkol. 2002 Sep;178(9):486-90. doi: 10.1007/s00066-002-1007-7. Strahlenther Onkol. 2002. PMID: 12426834 Clinical Trial.

7

The clinical value of squamous cell carcinoma antigen in patients irradiated for locally advanced cancer of the head and neck.

Micke O, Bruns F, Schäfer U, Horst E, Büntzel J, Willich N. Micke O, et al. Among authors: willich n. Anticancer Res. 2003 Mar-Apr;23(2A):907-11. Anticancer Res. 2003. PMID: 12820321

8

Adjuvant radiotherapy in locally confined prostate cancer.

Schäfer U, Witt F, Micke O, Willich N. Schäfer U, et al. Among authors: willich n. Anticancer Res. 2003 Mar-Apr;23(2A):983-5. Anticancer Res. 2003. PMID: 12820335

9

Carcinoembryonic antigen (CEA)--a useful marker for the detection of recurrent disease in endometrial carcinoma patients.

Bruns F, Micke O, Halek G, Schäfer U, Willich N. Bruns F, et al. Among authors: willich n. Anticancer Res. 2003 Mar-Apr;23(2A):1103-6. Anticancer Res. 2003. PMID: 12820355

10

Hemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumors.

Schäfer U, Micke O, Müller SB, Schüller P, Willich N. Schäfer U, et al. Among authors: willich n. Strahlenther Onkol. 2003 Aug;179(8):527-34. doi: 10.1007/s00066-003-1117-x. Strahlenther Onkol. 2003. PMID: 14509951

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters